| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.00069 | 1 |